OncoMatch/Clinical Trials/NCT06968221
Bovine Reinforcement in Stomach, Colorectal and Lung Operation
Is NCT06968221 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies Bioabsorbable Staple Line Reinforcemen for rectal cancer stage iii.
Treatment: Bioabsorbable Staple Line Reinforcemen — The primary purpose of this prospective, randomized multicenter center study is to evaluate and compare the outcomes of stomach,colorectal and lung anastomoses reinforced with a bioabsorbable staple line reinforcement material compared with standard non-reinforced techniques with respect to the incidence of postoperative hemorrage rate, anastomotic leakage, if applicable.
Check if I qualifyExtracted eligibility criteria
Cancer type
Colorectal Cancer
Non-Small Cell Lung Carcinoma
Disease stage
Required: Stage III
Lab requirements
Kidney function
creatinine <= 1.6
Liver function
liver enzymes <= 50% upper limit of normal values
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify